X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3299) 3299
Book Review (1145) 1145
Publication (467) 467
Book / eBook (196) 196
Book Chapter (73) 73
Conference Proceeding (16) 16
Reference (4) 4
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3044) 3044
animals (2251) 2251
humans (1775) 1775
male (788) 788
mice (768) 768
neurosciences (718) 718
rats (624) 624
female (562) 562
receptors (463) 463
physiology (446) 446
cell biology (444) 444
biochemistry & molecular biology (435) 435
endocrinology & metabolism (417) 417
physiological aspects (404) 404
research (399) 399
gene expression (393) 393
pharmacology & pharmacy (372) 372
vasoactive-intestinal-peptide (367) 367
signal transduction (361) 361
expression (351) 351
rodents (336) 336
proteins (335) 335
molecular sequence data (324) 324
neurons (315) 315
immunology (310) 310
cells, cultured (301) 301
peptides (289) 289
receptor (284) 284
multidisciplinary sciences (282) 282
article (281) 281
analysis (278) 278
rna, messenger - metabolism (278) 278
amino acid sequence (271) 271
inflammation (271) 271
neuropeptides (262) 262
cyclase-activating polypeptide (259) 259
mice, inbred c57bl (253) 253
cells (246) 246
immunohistochemistry (237) 237
medicine (232) 232
brain (230) 230
nervous system (215) 215
biomedicine (209) 209
gene-expression (209) 209
messenger-rna (208) 208
pituitary adenylate cyclase-activating polypeptide (207) 207
neurology (206) 206
rna, messenger - genetics (204) 204
mice, knockout (198) 198
rats, sprague-dawley (197) 197
reverse transcriptase polymerase chain reaction (193) 193
pacap (191) 191
genetic aspects (189) 189
health aspects (188) 188
research article (188) 188
vasoactive intestinal peptide - metabolism (187) 187
abridged index medicus (181) 181
vip (180) 180
vasoactive intestinal peptide - pharmacology (175) 175
central-nervous-system (164) 164
base sequence (162) 162
hormones, hormone substitutes, and hormone antagonists (162) 162
vasoactive intestinal peptide (162) 162
neurons - metabolism (161) 161
cytokines (160) 160
cell line (158) 158
gene-related peptide (158) 158
vasoactive intestinal polypeptide (158) 158
medicine & public health (157) 157
adult (156) 156
science (154) 154
pharmacology (153) 153
genes (149) 149
hormones (149) 149
disease models, animal (148) 148
gene expression regulation (148) 148
in-vitro (146) 146
review (145) 145
cyclic amp - metabolism (144) 144
ligands (144) 144
in-vivo (143) 143
receptors, vasoactive intestinal peptide - genetics (143) 143
biology (142) 142
cancer (140) 140
oncology (140) 140
rat (136) 136
life sciences (132) 132
rats, wistar (132) 132
activation (130) 130
gastroenterology & hepatology (129) 129
biochemistry (126) 126
molecular-cloning (126) 126
receptors, pituitary adenylate cyclase-activating polypeptide (126) 126
middle aged (125) 125
signal transduction - physiology (124) 124
care and treatment (123) 123
neuropeptides - metabolism (122) 122
polymerase chain reaction (122) 122
substance-p (122) 122
brain - metabolism (120) 120
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (152) 152
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
UTL at Downsview - May be requested (7) 7
UofT at Mississauga - Stacks (7) 7
Online Resources - Online (5) 5
UofT at Scarborough - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3519) 3519
Spanish (12) 12
Japanese (6) 6
French (4) 4
German (4) 4
Chinese (3) 3
Arabic (1) 1
Hebrew (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 03/2011, Volume 471, Issue 7339, pp. 499 - 503
Journal Article
Journal of Leukocyte Biology, ISSN 0741-5400, 12/2016, Volume 100, Issue 6, pp. 1385 - 1393
VIP neuropeptide counterbalances the pro‐inflammatory profile of in vitro GM‐CSF‐polarized macrophages in favor of anti‐inflammatory function. This study... 
granulocyte | anti‐inflammatory | human monocyte | inflammation | rheumatoid arthritis | Inflammation | Human monocyte | Anti-inflammatory | Rheumatoid arthritis | Granulocyte | RHEUMATOID-ARTHRITIS | ACTIVATION | IMMUNE CELLS | VASOACTIVE-INTESTINAL-PEPTIDE | ARTHRITIS SYNOVIAL FIBROBLASTS | INFLAMMATORY DISEASES | RECEPTOR EXPRESSION | IMMUNOLOGY | CELL BIOLOGY | AUTOIMMUNE | IN-VIVO | anti-inflammatory | HEMATOLOGY | T-CELLS | Up-Regulation | Humans | Receptors, Vasoactive Intestinal Polypeptide, Type I - drug effects | Receptors, Vasoactive Intestinal Peptide, Type II - biosynthesis | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Receptors, Vasoactive Intestinal Peptide, Type II - physiology | RNA, Messenger - biosynthesis | Receptors, Vasoactive Intestinal Peptide, Type II - drug effects | Vasoactive Intestinal Peptide - pharmacology | Macrophage Colony-Stimulating Factor - pharmacology | Synovial Fluid - cytology | Cyclic AMP - metabolism | Cytokines - genetics | Receptors, Vasoactive Intestinal Polypeptide, Type I - biosynthesis | Cells, Cultured | Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology | Receptors, Vasoactive Intestinal Polypeptide, Type I - physiology | Immunophenotyping | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Arthritis, Rheumatoid - pathology | Gene Expression Regulation - drug effects | Macrophages - metabolism | Macrophages - drug effects | Macrophage Activation - drug effects | Cytokines - biosynthesis | Index Medicus
Journal Article
Journal Article
Cephalalgia, ISSN 0333-1024, 1/2011, Volume 31, Issue 2, pp. 181 - 189
Objective: We pharmacologically characterized pituitary adenylate cyclase–activating polypeptides (PACAPs), vasoactive intestinal peptide (VIP) and the VPAC1,... 
PAC1 | PACAP38 | VPAC1 | VIP | VPAC2 | CYCLASE-ACTIVATING POLYPEPTIDE | RAT | IMMUNOHISTOCHEMICAL LOCALIZATION | MIGRAINE | NEUROSCIENCES | PEPTIDE | CLINICAL NEUROLOGY | PAC | VPAC | MESSENGER-RNA | HEADACHE | CEREBRAL-ARTERIES | HEALTHY-VOLUNTEERS | EXPRESSION | Pituitary Adenylate Cyclase-Activating Polypeptide - antagonists & inhibitors | Receptors, Vasoactive Intestinal Polypeptide, Type I - antagonists & inhibitors | Gene Expression - drug effects | Receptors, Vasoactive Intestinal Peptide, Type II - agonists | Humans | Middle Aged | Male | Peptide Fragments - pharmacology | Receptors, Vasoactive Intestinal Peptide - genetics | RNA, Messenger - metabolism | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Meningeal Arteries - physiology | Vasoactive Intestinal Peptide - pharmacology | Receptors, Vasoactive Intestinal Polypeptide, Type I - agonists | Gene Expression - physiology | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Migraine Disorders - physiopathology | Adult | Female | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - agonists | Vasodilation - physiology | Coronary Vessels - drug effects | Receptors, Vasoactive Intestinal Peptide, Type II - antagonists & inhibitors | Vasodilator Agents - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - genetics | Coronary Vessels - physiology | Pituitary Adenylate Cyclase-Activating Polypeptide - adverse effects | Meningeal Arteries - drug effects | Migraine Disorders - drug therapy | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Aged | Receptors, Vasoactive Intestinal Peptide - antagonists & inhibitors | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Vasodilation - drug effects | Receptors, Vasoactive Intestinal Peptide - agonists | Vasoactive Intestinal Peptide - analogs & derivatives | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - antagonists & inhibitors | Index Medicus
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 02/2018, Volume 38, Issue 6, pp. 1326 - 1334
1 In mammals, the suprachiasmatic nucleus (SCN) of the hypothalamus coordinates daily rhythms including sleep-wake, hormone release, and gene expression. The... 
VIP | Ontogeny | Clock genes | EMBRYONIC-DEVELOPMENT | RAT | MAMMALIAN CLOCK NEURONS | FETAL BIOLOGICAL CLOCK | TIME | ontogeny | NEUROSCIENCES | clock genes | IN-VITRO | VPAC RECEPTOR | MESSENGER-RNA | CELLULAR RHYTHMICITY | EXPRESSION | Period Circadian Proteins - physiology | Vasoactive Intestinal Peptide - metabolism | Mice, Inbred C57BL | Male | Circadian Rhythm - physiology | Vasoactive Intestinal Peptide - antagonists & inhibitors | Receptors, Vasoactive Intestinal Peptide, Type II - biosynthesis | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | GABA Antagonists - pharmacology | Suprachiasmatic Nucleus - physiology | Pregnancy | Animals | Aging - genetics | Aging - physiology | Period Circadian Proteins - genetics | Vasoactive Intestinal Peptide - physiology | Neurons - physiology | Suprachiasmatic Nucleus - cytology | Suprachiasmatic Nucleus - growth & development | Female | Mice | Suprachiasmatic nucleus | Cycles | Oscillations | Antagonists | Hypothalamus | CLOCK protein | Proteins | Hormone release | γ-Aminobutyric acid | Embryogenesis | Intestine | Vasoactive agents | Period 2 protein | Sleep and wakefulness | Circadian rhythms | Fetuses | Periodicity | Mammals | Gene expression | Periodic variations | Oscillators | Embryonic growth stage | Sleep | Vasoactive intestinal peptide | Index Medicus | s
Journal Article
FASEB Journal, ISSN 0892-6638, 06/2016, Volume 30, Issue 6, pp. 2198 - 2210
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 12/2015, Volume 35, Issue 50, pp. 16463 - 16478
Vasoactive intestinal peptide (VIP) mediates a broad range of biological responses by activating two related receptors, VIP receptor 1 and 2 (VIPR1 and VIPR2).... 
Neuroprotection | Adaptive immunity | Inflammation | VPAC | VIP | Parkinson’s disease | CYCLASE-ACTIVATING POLYPEPTIDE | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | ACTION IN-VIVO | Parkinson's disease | VASOACTIVE-INTESTINAL-PEPTIDE | NEUROSCIENCES | adaptive immunity | ALPHA-HELIX MIMICRY | EXPERIMENTAL ARTHRITIS | inflammation | neuroprotection | MOUSE MODEL | REGULATORY T-CELLS | ADENYLATE-CYCLASE | PARKINSONS-DISEASE | Immunohistochemistry | Neuroprotective Agents - therapeutic use | Tyrosine 3-Monooxygenase - metabolism | Cricetulus | Substantia Nigra - pathology | Humans | MPTP Poisoning - physiopathology | Receptors, Vasoactive Intestinal Polypeptide, Type I - drug effects | Spleen - drug effects | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Microglia - immunology | Receptors, Vasoactive Intestinal Peptide, Type II - drug effects | Dopaminergic Neurons - drug effects | MPTP Poisoning - immunology | CHO Cells | Substantia Nigra - enzymology | Cell Line | Cricetinae | Dopaminergic Neurons - immunology | Cytokines - metabolism | Microglia - drug effects | Mice, Inbred C57BL | Oligopeptides - pharmacokinetics | CD4-Positive T-Lymphocytes - metabolism | Spleen - cytology | MPTP Poisoning - drug therapy | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Animals | Mice | Oligopeptides - pharmacology | Receptors, Vasoactive Intestinal Peptide - agonists | Index Medicus
Journal Article
Journal of Experimental Zoology Part A: Ecological Genetics and Physiology, ISSN 1932-5223, 07/2014, Volume 321, Issue 6, pp. 334 - 347
Journal Article
Peptides, ISSN 0196-9781, 09/2012, Volume 37, Issue 1, pp. 32 - 39
► Streptozotocin (STZ) treatment diminishes retinal expression of PACAP and VIP. ► STZ-induced diabetes decreases Bcl2 and increases p53 expression in retina.... 
Diabetic retinopathy | Retina | PACAP | Rat | VIP | Streptozotocin | SIGNALING PATHWAYS | NEURAL APOPTOSIS | PROTEIN-KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | I RECEPTOR | CELL-DEATH | MESSENGER-RNA | POLYPEPTIDE PACAP | PHARMACOLOGY & PHARMACY | INDUCED NEUROTOXICITY | UP-REGULATION | ENDOTHELIAL GROWTH-FACTOR | Vasoactive Intestinal Peptide - metabolism | Retina - metabolism | Gene Expression - drug effects | Intravitreal Injections | Streptozocin | Male | DNA Primers - genetics | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Tumor Suppressor Protein p53 - genetics | Diabetes Mellitus, Experimental - blood | Proto-Oncogene Proteins c-bcl-2 - metabolism | Base Sequence | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - metabolism | Diabetes Mellitus, Experimental - metabolism | Receptors, Vasoactive Intestinal Peptide, Type II - metabolism | Tumor Suppressor Protein p53 - metabolism | Blood Glucose | Rats, Sprague-Dawley | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Animals | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Pituitary Adenylate Cyclase-Activating Polypeptide - administration & dosage | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Ophthalmology | Vasoactive intestinal peptides | Tumor proteins | Index Medicus
Journal Article
Journal Article
Journal Article